| Apremilast |
Tablet |
II (Paddle) |
60 |
0.15% SLS in 25 mM Sodium Phosphate Buffer, pH 6.8 |
900 |
10, 15, 20, 30, and 45 |
2017/05/18 |
| Aprepitant |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Aprepitant |
Emulsion |
|
|
Develop a method to characterize in vitro release |
|
|
2024/02/05 |
| Aprepitant |
For Oral Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Aprocitentan |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.8 w/0.05% CTAB and 0.5% Tween 20 |
900 |
10, 15, 20, 30 and 45 |
2025/02/24 |
| Aripiprazole |
Suspension (Extended Release) |
IV (Flow through Cell) with closed system |
4 mL/min |
Acetate buffer, pH 5.0 |
1000 |
0.5, 0.75, 1, 2, 4, 6, 8, 10, 12, 14, 16 and 18 hours |
2024/11/01 |
| Aripiprazole |
Tablet (Orally Disintegrating) |
II (Paddle) |
75 |
Acetate Buffer, pH 4.0 |
1000 |
10, 20, 30 and 45 |
2008/08/11 |
| Aripiprazole |
For Intramuscular Suspension (Extended Release) |
II (Paddle) |
50 |
0.25% Sodium Dodecyl Sulfate (SDS) Solution |
900 |
10, 15, 30, 60, 120, 180, 240, 300, 360, 420 and 480 |
2015/06/25 |
| Aripiprazole |
Tablet |
|
|
Refer to USP |
|
|
2016/06/30 |
| Armodafinil |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2008/01/14 |
| Asciminib HCl |
Tablet |
II (Paddle) |
60 |
Citrate Buffer, pH 3.0 |
900 |
5, 10, 15, 20 and 45 |
2023/10/06 |
| Asenapine |
Transdermal |
VI (Cylinder) |
50 |
pH 5.1 Acetate Buffer at 32°C |
900 |
1, 2, 3, 4, 6, 8, 10 and 12 hours |
2021/04/22 |
| Asenapine Maleate |
Tablet (Sublingual) |
II (Paddle) |
50 |
Acetate Buffer, pH 4.5 |
500 |
1, 2, 3, 4 and 5 |
2013/05/09 |
| Aspirin |
Capsule |
|
|
Refer to USP |
|
|
2015/05/28 |
| Aspirin |
Capsule (Extended Release) |
II (Paddle) with sinker |
100 |
0.05M Potassium Phosphate Buffer (pH 7.4) with trypsin (.001%w/v) and sodium azide (.025% w/v) |
900 |
1, 2, 3, 6, 9, 12, 16, 22 and 30 hours |
2016/10/20 |
| Aspirin/ Omeprazole |
Tablet (Delayed Release) |
I (Basket) |
100 |
Acid Stage: 0.1 N HCl (degassed); Buffer Stage: Phosphate Buffer, pH 6.8 (degassed) |
Acid Stage: 900; Buffer Stage: 900 |
Acid Stage:120; Buffer Stage:10, 20, 30, 45, 60 and 75 |
2016/12/22 |
| Aspirin/Butalbital/Caffeine |
Capsule |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Aspirin/Butalbital/Caffeine |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Aspirin/Butalbital/Caffeine/Codeine Phosphate |
Capsule |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Aspirin/Caffeine/Orphenadrine Citrate |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
请输入需要查询的英文药品通用名称，至少3个字符.